Fresenius Medical Care Files 6-K with Press Release
Ticker: FMCQF · Form: 6-K · Filed: May 23, 2024 · CIK: 1333141
| Field | Detail |
|---|---|
| Company | Fresenius Medical Care Ag (FMCQF) |
| Form Type | 6-K |
| Filed Date | May 23, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release
Related Tickers: FMS
TL;DR
FMC dropped a 6-K with a press release today - check Exhibit 99.1 for the deets.
AI Summary
Fresenius Medical Care AG filed a Form 6-K on May 23, 2024, to report a press release issued on the same date. The press release, Exhibit 99.1, is the primary content of this filing, indicating new information or updates from the company. The filing itself does not contain specific financial figures or operational details beyond referencing the attached press release.
Why It Matters
This filing signals that Fresenius Medical Care has new information to share with investors, likely detailed in the accompanying press release, which could impact the company's stock.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves to attach a press release, with no immediate new financial or operational data presented directly in the form.
Key Players & Entities
- Fresenius Medical Care AG (company) — Registrant
- May 23, 2024 (date) — Filing date and press release date
- Exhibit 99.1 (document) — Attached press release
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report a press release issued by Fresenius Medical Care AG on May 23, 2024, as Exhibit 99.1.
What is the filing date of this report?
The filing date of this report is May 23, 2024.
What is the primary document attached to this 6-K?
The primary document attached to this 6-K is Exhibit 99.1, which is a press release issued by Fresenius Medical Care AG.
Under which act is this report filed?
This report is filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What is the company's principal executive office address?
The company's principal executive offices are located at Else-Kröner Strasse 1, 61346 Bad Homburg, Germany.
Filing Stats: 177 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2024-05-23 14:11:33
Filing Documents
- tm2415438d1_6k.htm (6-K) — 10KB
- tm2415438d1_ex99-1.htm (EX-99.1) — 12KB
- tm2415438d1_ex99-1img001.jpg (GRAPHIC) — 5KB
- 0001104659-24-064647.txt ( ) — 30KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DATE: May 23, 2024 Fresenius Medical Care AG By: /s/ Helen Giza Name: Helen Giza Title: Chief Executive Officer and Chair of the Management Board By: /s/ Martin Fischer Name: Martin Fischer Title: Chief Financial Officer and member of the Management Board